SCHEMBL20683046

SCHEMBL20683046

CC(C)c1nc2ccc(C(=O)N3CCN(C)CC3)cc2[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 8/20 0.58
HRH3 Q9Y5N1 1/20 0.57
FGFR1 P11362 2/20 0.53
KDR P35968 2/20 0.53
PDGFRB P09619 1/20 0.53
HPGD P15428 1/20 0.53
TSHR P16473 1/20 0.53
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
ALOX15 P16050 1/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
FGFR2 P21802 1/20 0.49
FGFR3 P22607 1/20 0.49
PIK3CD O00329 1/20 0.49
PIK3CB P42338 1/20 0.49
MTOR P42345 1/20 0.49
TLR9 Q9NR96 1/20 0.49
TLR8 Q9NR97 1/20 0.49
TLR7 Q9NYK1 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17468532 0.84 HRH4 (0.62) HRH4HRH3FGFR1KDRPDGFRB
SCHEMBL20683090 0.82 HRH4 (0.57) HRH4HRH3FGFR1KDRPDGFRB
SCHEMBL20765776 0.79 ALDH1A1 (0.54) HRH3ALDH1A1MEN1KMT2A
SCHEMBL20313106 0.79 TSHR (0.56) HRH4HRH3FGFR1KDRPDGFRB
SCHEMBL18785691 0.77 MLKL (0.68) HPGDALDH1A1
SCHEMBL20683048 0.76 CHEK2 (0.57)
SCHEMBL25138043 0.75 FGFR1 (0.55) HRH4HRH3FGFR1KDRPDGFRB
SCHEMBL12431599 0.74 SMN1; SMN2 (0.70) HPGDTSHRALDH1A1MAPTMEN1
SCHEMBL18341894 0.74 HSD17B10 (0.55) HRH4HRH3FGFR1KDRPDGFRB
SCHEMBL22955526 0.74 KDR (0.65) HRH4HRH3FGFR1KDRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10189830-B2 Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders BIOELECTRON TECHNOLOGY CORPORATION (US) 2019-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189830-B2 Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders NQO1, COQ8A, NDUFAB1 HRH4 3981/4885HRH3 4189/4885FGFR1 3974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.